First Tracks Biotherapeutics, Inc. (TRAX)

NASDAQ: TRAX · Real-Time Price · USD

35.83

-0.83 (-2.26%)

At close: Sep 24, 2026, 4:00 PM EDT

36.00

+0.17 (0.47%)

Pre-market: Sep 25, 2026, 8:07 AM EDT

TRAX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	51.1	39.39	28.76	20.87
Research & Development	118.48	139.61	152.35	90.26
Operating Expenses	169.58	179.01	181.1	111.12
Operating Income	-169.58	-179.01	-181.1	-111.12
Interest & Investment Income	9.28	12.94	17.38	12.31
Other Non Operating Income (Expenses)	-0.01	-0.02	0.01	-0
EBT Excluding Unusual Items	-160.3	-166.09	-163.71	-98.81
Pretax Income	-160.3	-166.09	-163.71	-106.15
Net Income	-160.3	-166.09	-163.71	-106.15
Net Income to Common	-160.3	-166.09	-163.71	-106.15
Net Income Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-123.82	-143.01	-126.16	-93.81
EBITDA	-169.08	-178.45	-180.5	-110.47
D&A For EBITDA	0.5	0.56	0.61	0.65
EBIT	-169.58	-179.01	-181.1	-111.12